Eli Lilly and CompanyLLYNYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank21
Year-over-Year Change
Year-over-year free cash flow growth rate
Latest
-92.13%
↓ 248% vs avg
Percentile
P21
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
62.26%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -92.13% |
| Q3 2025 | 571.24% |
| Q2 2025 | 180.14% |
| Q1 2025 | -320.33% |
| Q4 2024 | 258.34% |
| Q3 2024 | -823.82% |
| Q2 2024 | -64.72% |
| Q1 2024 | 109.15% |
| Q4 2023 | -8.35% |
| Q3 2023 | -786.35% |
| Q2 2023 | -124.71% |
| Q1 2023 | -19.24% |
| Q4 2022 | -34.55% |
| Q3 2022 | 323.21% |
| Q2 2022 | -77.48% |
| Q1 2022 | -6.83% |
| Q4 2021 | 49.89% |
| Q3 2021 | -5.51% |
| Q2 2021 | 3.23% |
| Q1 2021 | 21.05% |
| Q4 2020 | -28.44% |
| Q3 2020 | -29.44% |
| Q2 2020 | 1489.20% |
| Q1 2020 | -92.42% |
| Q4 2019 | 40.05% |
| Q3 2019 | 52.57% |
| Q2 2019 | 958.01% |
| Q1 2019 | -110.82% |
| Q4 2018 | -54.72% |
| Q3 2018 | 634.78% |
| Q2 2018 | -270.35% |
| Q1 2018 | -84.00% |
| Q4 2017 | -12.79% |
| Q3 2017 | 0.27% |
| Q2 2017 | 736.45% |
| Q1 2017 | -89.66% |
| Q4 2016 | 15.39% |
| Q3 2016 | 23.80% |
| Q2 2016 | 409.72% |
| Q1 2016 | -249.30% |